** Shares of Neuren Pharmaceuticals NEU.AX rise as much as 8.4% to A$17.940, their highest since Aug. 5
** Stock biggest pct gainer on the benchmark S&P/ASX 200 index .AXJO
** Drug manufacturer announces commencement of on-market share buyback programme of up to A$50 mln ($32.47 mln)
** Says will buy up to 3 mln shares at A$16.540 per share, based on the last close of Wednesday
** Stock down 33.8% YTD
($1 = 1.5401 Australian dollars)
(Reporting by Kumar Tanishk in Bengaluru)
((Tanishk.Kumar@thomsonreuters.com;))
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。